PATENT CLAIM ANALYSIS

Application Number: 16113564
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["514", "303000"]

Abstract:
The invention relates to a polymorphic form of (S)-3-(3-(1-methyl-2-oxo-5-(pyrazolo[1,5-a]pyridine-3-yl)-1H-imidazo[4,5-b]pyridine-3(2H)-yl)piperidin-1-yl)-3-oxopropanenitrile and use as a therapeutic agent for the treatment of respiratory diseases.

Claim (Index 5):
A method of treating a respiratory disorder, comprising administering to a patient in need thereof a polymorph of (S)-3-(3-(1-methyl-2-oxo-5-(pyrazolo[1,5-a]pyridine-3-yl)-1H-imidazo[4,5-b]pyridine-3(2H)-yl)piperidin-1-yl)-3-oxopropanenitrile with the following diffraction angles (2Theta) based on cupric K\u03b11:\n at approximately 8.25\u00b0; at approximately 13.25\u00b0; at approximately 15.40\u00b0; at approximately 17.65\u00b0; and at approximately 25.39\u00b0.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 96.0
- Lexical Diversity: 1.32432
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15547657', '15555590', '14118377', '14386424', '14442860']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6977541878787152
- 35 USC 102 Novelty (BERT): 0.5632353564901521
- Combined Prediction Score: 0.6843023047398589
- Mean Citation Score: 263.678292
- Max Citation Score: 441.31512
- Similarity Product: 327.456995584588

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test